Stay updated on INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change in ClinicalTrials.gov’s site build rather than any study content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check45 days agoChange Detected- Added revision: v3.4.3. - The previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 was added, and the notice about lapse in government funding as well as the older Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page revision was updated to v3.4.1, replacing the prior v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.